Skip to main content
. 2022 Nov 30;14(23):5086. doi: 10.3390/nu14235086

Table 4.

All reviewed studies investigating the effects of DR in MS. N/A: relevant data not reported; n/s: relevant data not significant; EAE: experimental autoimmune encephalomyelitis; SCH: spinal cord homogenate; PLP: proteolipid protein; MOG: myelin oligodendrocyte glycoprotein; CNS: central nervous system; BHB: beta-hydroxybutyrate; RRMS: relapsing remitting multiple sclerosis; QOL: quality of life.

1 Multiple Sclerosis Animal Studies
Model Organism (Antigen) Age & Sex Dietary Interventions Clinical Findings Immune & Biomarkers Reference
Lewis rats, EAE (SCH) 6-weeks male 66% CR for 15 days pre-induction ↓ clinical score ↓ spleen & lymph IFN-γ Esquifino et al. 2007 [132]
SJL mice, EAE (PLP) 5-weeks female 40% CR for 5 weeks pre-induction ↓ clinical score; ↑ survival; ↓ spinal cord inflammation, demyelination, & axon damage ↑ corticosterone & adiponectin; ↓ leptin & IL-6 Piccio et al. 2008 [133]
C57BL/6 mice, EAE (MOG) 13-weeks female ADF for 8 weeks pre-induction, post-induction, or both ↓ incidence (ADF post) N/A Kafami et al. 2010 [134]
C57BL/6 mice, EAE (MOG) 10-weeks female FMD (3 cycles) at 10% symptomatic (S), at 100% symptomatic (T), or at 2 weeks post-symptoms (C-F) ↓ clinical score (all); ↓ incidence (S); ↓ spinal cord inflammation & demyelination (T); ↑ myelin regeneration (T) ↓ blood WBC, lymphocytes, monocytes, & granulocytes; ↓ CNS CD4 & CD8 T-cells; ↑ spleen naïve:active CD4 T-cell ratio (T) Choi et al. 2016 [136]
C57BL/6 mice, EAE (MOG) 7-weeks female ADF for 4 weeks pre-induction ↓ clinical score; ↓ spinal cord inflammation & demyelination; ↓ lymph T-cell IL-17 & IFN-γ; ↑ corticosterone & BHB; ↑ T-regs in small intestine Cignarella et al. 2018 [135]
C57BL/6 mice, EAE (MOG) 8 weeks-female ADF for 4 weeks pre-induction ↓ clinical score ↓ blood & CNS inflammatory monocytes; ↓ CNS monocyte TNFα, IL-1β, CXCL2 &CXCL10 Jordan et al. 2019 [55]
C57BL/6 mice, EAE (MOG) 6-weeks female FMD (2 cycles) at 3 weeks post-induction ↓ incidence; ↓ clinical score; ↓ spinal cord inflammation & demyelination; ↑ myelin regeneration ↓ spinal cord leukocytes & macrophages; ↓ CNS CD4 & CD8 T-cells; ↓ CNS T-cell IL-17 &↑ IFN-γ; ↑ spleen CD4 & CD11b T-cells Bai et al. 2021 [137]
2 Multiple Sclerosis Human Studies
Patient Population Age & Sex Dietary Interventions Clinical Findings Immune & Biomarkers Reference
Adult RRMS patients 18–68 (mean: 45) male & female 1-cycle of FMD followed by a Mediterranean diet (n = 18), KD (n = 18), or control diet (n = 12) for 6 months ↑ QOL (FMD & KD) n/s Choi et al. 2016 [136]
Adult RRMS patients undergoing relapse 18–60 (mean: 41) male & female <500 kcal ADF (n = 8) or control diet (n = 8) for 15 days n/s ↓ blood T&B cells; ↓ naïve CD4 T-cells; ↓ Leptin Cignarella et al. 2018 [135]
Adult RRMS patients not undergoing relapse 18–50 (mean: 37) male & female 75% CR 5:2 IF (n = 11), 22% CR (n = 11), or control diet (n = 9) for 8 weeks n/s ↓ memory T-cells and Th1 cells ↑ naïve CD4 T-cells Fitzgerald et al. 2022 [138]